Category Innovation/ R&D

Medicines Innovation And Access: Swiss Stimulate New Thinking

BERN, Switzerland -- What if reaching the United Nations Sustainable Development Goals on access to health for all depended on the willingness of all actors to see beyond outdated dichotomies? The concept may seem obvious, but is easier described than done. In an effort to break silos, the Swiss Federal Institute of Intellectual Property (IPI) brought together stakeholders of all sides last week to discuss how to harness political and economic will to achieve innovation leading to new medicines that are available and affordable for all in need.

Importance Of Flu Pandemic Preparedness Confirmed By WHO Board Decision

One hundred years after the great Spanish flu pandemic, World Health Organization members today underlined their satisfaction with the organisation’s framework to get countries best prepared for the next pandemic: The WHO Executive Board agreed on keeping most of the funds coming to the framework for preparedness measures, and a smaller portion for response measures, unless emergency strikes.

WHO Executive Board Agrees On Actions To Boost R&D, Access To Medicines

After long deliberations, the World Health Organization Executive Board agreed this morning to ask member states and the organisation to implement recommendations aiming at improving innovation and access to medicines. Three recommendations, specifically aimed at member states, including on the transparency on the cost of research and development of medicines, met resistance by some countries and were left hanging, to be discussed by member states with no timeframe.

New Text Shows Progress Of Negotiation On IP And Access At WHO

The Brazilian ambassador and others this morning at the World Health Organization Executive Board meeting were not going to let go of what seemed to be a delaying tactic by the United States and Japan to postpone agreement on the implementation of measures aimed at facilitating research and development and access to medicines. The WHO Board today is considering a set of streamlined strategic measures on public health, innovation, and intellectual property.

WHO Board Shows Resolve In Tackling Shortages, Access To Medicines, Vaccines

The members of the World Health Organization Executive Board tonight (24 January) agreed to create a roadmap on global shortages of, and access to, medicines and vaccines. WHO members proclaimed the urgent need to address prices and availability of safe and efficient medicines and vaccines, some requesting the recently elected director general of the organisation to help find solutions.

WHO Members Set To Debate Transparency Of R&D Costs

World Health Organization Executive Board members and observer countries today are preparing to discuss recommendations on ways to lower prices and make medicines more accessible. This includes a new proposal to increase transparency in research and development costs that is reportedly causing concern among some developed countries.